Searched for
GSK SPOKESPERSON
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- No plans to reintroduce Zinetac in India: GSKBritish drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, de...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- GSK files patent suit against GlenmarkGSK was granted a patent for vilanterol in India in 2007. The patent expires in September 2022.
- GSK consumer MD to head residual business post HUL deal completionThe unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...
- Ranitidine under lens after carcinogen alertIn India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug.
- GSK to recall Ranitidine from India after regulator alertBritish drugmaker will suspend release, distribution and supply of the heartburn drug.
- Won’t transfer key technology to HUL: GSK Consumer to CourtUnilever Plc’s India unit said on December 3 it would merge GSK Consumer with itself in an all-stock deal that will give it access to Horli...
- GSK Consumer Healthcare to fight case against tech transferGSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process ...
- Teams to plan staff integration or separation in GSK-HUL dealGSK chief strategy officer said there is no clause in the deal that HUL has to retain all GSKCH employees.
- GlaxoSmithKline looks to set up Rs 1,000-crore health drink units in Andhra Pradesh“GSK is also looking at using a part of the production capacities at the proposed greenfield facility to cater to export markets.”
- Glaxo decides to cut price of Crocin by 50 per centGlaxo had stopped manufacturing Crocin from September 2012, and had launched the variant 'Crocin Advance' at a higher price.
- Lack of health link blamed as GSK cans 4 products in new foods categoryLack of health link blamed as Horlicks maker withdraws 4 products in 2 years in newer food segments.
- Parent offer talk spurs GSK PharmaIt may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...
- DCGI asks GSK to withdraw promotional advertisementNational health regulator Drug Controller General of India has asked GlaxoSmithKline to withdraw promotional advertisement for cervical can...
- GSK drug-deal talk lifts DRL scripShares of Dr Reddy’s Laboratories (DRL) touched an intra-day high of Rs 878.70, amid speculation that the Indian drug maker is in prelimina...
- Indian drug makers welcome to join 'patent pool' prog: GSKIndian drug makers and research cos can join 'patent pool' programme to develope low cost drugs for 16 neglected tropical diseases.
- Citi, Merrill, Novartis, GSK may shift Satyam contractsTroubles keep mounting for Satyam Computer Services. Four of its large clients - Citigroup, Merrill Lynch (ML), Novartis and GlaxoSmith Kle...
- GSK drops claims on two AIDS medicinesIn a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...
Load More
